Shailesh Maingi is Founder and CEO of Kineticos Life Sciences in 2007, a boutique life sciences management consulting practice serving pharmaceutical, biotechnology, precision medicine, diagnostic, contract research organizations and private equity clients. In addition to leading Kineticos, he is Adjunct Faculty at the  Kenan-Flagler School of Business at UNC-Chapel Hill. Mr. Maingi also serves on the Board of Directors at Prevention Partners, a non-profit with a mission of preventing disease. In addition, Mr. Maingi has served on a number of board positions including Gallus Biopharmaceutical, a biologics CMO, Novolipid and Enci Therapeutics, two start up pre-clinical oncology biotechs.  Prior to founding Kineticos Life Sciences, Mr. Maingi was a senior executive at Cardinal Health and Sigma-Aldrich where he held leadership roles in strategy, business development and marketing. Mr. Maingi earned a BS in Chemistry from UNC at Chapel Hill and an MBA.